DOCSLIB.ORG

ACG 2010! the Premier GI Clinical Event of the Year!

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ACG 2010! the Premier GI Clinical Event of the Year! Welcome to ACG 2010! The Premier GI Clinical Event of the Year! Dear Colleagues, Welcome to ACG 2010, ACG’s Annual Scientific Meeting and Postgraduate Course, the premier GI clinical event of the year. The Postgraduate Course Directors and ACG’s Educational Affairs Committee, along with Friday Course Directors, have brought together internationally recognized experts and rising stars in the field. This year’s program promises to deliver the latest clinical updates in gastroenterology and hepatology, plus discuss what is on the horizon that may impact your practice. The College is launching new this year a Hands-on Workshop Center. Located in the Exhibit Hall, the Hands-on Workshop Center features 13 sessions including Foreign Body Removal, Principles and Techniques of Expandable Stents, Hemostatic Devices, Advanced Endsocopy, Bleeding Therapy, Other Endoscopy Imaging, and more. Space is limited for these sessions and you must pre-register. See page 14 for the full list of sessions and how to register. Other new activities taking place this year include an Exhibitor Theater presentation by GIQuIC, the GI Quality Improvement Consortium Ltd. If you’ve been considering participating in an outcomes registry, I encourage you to attend this half-hour session on Sunday, October 17, from 5:30 pm – 6:00 pm in the Exhibitor Theater Booth in the Exhibit Hall. GIQuIC’s President, Irving Pike, MD, FACG, will discuss how the GIQuIC can improve your clinical and business outcomes and how GIQuIC differs from other registries. We had a strong showing for abstract submissions this year, nearly matching last year’s best ever record. In total, you’ll find nearly 1,300 abstracts selected for either oral or poster presentation. I congratulate all of our colleagues for their research efforts and I encourage you to attend the oral presentations and to view the posters during the three-day Annual Meeting. We will again offer Poster Rounds with the Experts. Each day of the poster sessions, well known experts will lead attendees around to posters of interest. This is a great opportunity to discuss posters, garner insight from the experts, and make new contacts with other attendees in a low- key, relaxed atmosphere. Poster Rounds with the Experts runs from Sunday through Tuesday. Last but certainly not least is the President’s Reception. This year’s President’s Reception will be held on Monday evening, 6:15 pm – 7:45 pm, in the Exhibit Hall. It’s a great opportunity to mingle with your colleagues as you explore the latest diagnostic and therapeutic offerings from exhibitors. In closing, I want to thank you for the opportunity to serve you this year. It has been my great pleasure to be the ACG President and I welcome everyone to the ACG 2010 Annual Scientific Meeting and Postgraduate Course. Sincerely, Philip O. Katz, MD, FACG ACG President 1 Schedule at a Glance International Attendee Friday, October 15 Saturday, October 16 Sunday, October 17 Reception Grand Hyatt San Antonio, Texas Ballroom D Registration Continental Breakfast Continental Breakfast 6:00 pm - 7:00 pm East Registration Ballroom Foyer Ballroom Foyer 5:30 am - 8:00 pm 7:00 am - 7:45 am 7:00 am - 7:45 am Women and Minorities in GI Reception Continental Breakfast Registration Registration Grand Hyatt San Antonio, Outside Course rooms East Registration East Registration Seguin AB Room 6:30 am - 8:00 am 7:00 am - 5:15 pm 7:00 am - 6:30 pm 6:00 pm - 7:00 pm GI Pathology & Imaging Postgraduate Course Postgraduate Course Alumni Receptions Course Ballroom C Ballroom C Grand Hyatt San Antonio Room 217 AB 7:50 am - 5:00 pm 7:50 am - 5:00 pm 6:00 pm - 7:00 pm 7:00 am - 12:35 pm Auxiliary Registration/ Auxiliary Registration/ ASGE-Sponsored Hospitality Suite Hospitality Suite Monday, October 18 Endoscopy Course Grand Hyatt San Antonio, Grand Hyatt San Antonio, Room 217 CD Republic B Room Republic B Room 7:15 am - 5:00 pm 8:00 am - 12:00 noon 8:00 am - 12:00 noon Registration East Registration Practice Management ACG Store ACG Store 6:00 am - 5:45 pm Course 8:00 am - 5:15 pm 8:00 am - 5:15 pm Room 214 AB NEW ! Optional Breakfast 8:00 am - 5:00 pm David Sun Lecture Optional Learning Sessions Ballroom C Luncheons (Ticket required. See ticket What’s New in 10:00 am - 10:30 am (Ticket required. See ticket for room assignment.) GI Pharmacology Course for room assignment.) 6:30 am - 8:00 am Room 217 AB Optional Learning 12:20 pm - 1:35 pm NEW ! GI Mid-level Providers 1:45 pm - 5:00 pm Luncheons Trainees Luncheon (Ticket required. See ticket Breakfast ACG Store for room assignment.) Room 210 A Room 215 2:00 pm - 6:00 pm 12:20 pm - 1:35 pm 12:20 pm - 1:35 pm 6:30 am - 8:00 am NEW! Networking, Negotiating and Career Opportunities for GI Mid-level Providers Annual Meeting Luncheon Leadership Skills Workshop Women in GI Luncheon Room 210 B Ballroom C Rooms 209 & 211 Room 210 A 12:20 pm - 1:35 pm 7:50 am - 5:45 pm 4:00 pm - 8:00 pm 12:20 pm - 1:35 pm Auxiliary Registration/ Exhibit Hall Opens Hospitality Suite Recertification Preparation GI Jeopardy Exhibit Hall CD and Update Course Room 214 A-C 3:30 pm - 7:00 pm Grand Hyatt San Antonio, Room 207 5:15 pm - 7:00 pm Republic B Room ! 8:00 am - 12:00 noon 5:30 pm - 9:00 pm NEW Hands-on Workshop Center Exhibit Hall – Booth 1313 ACG Store 3:30 pm - 7:00 pm 8:00 am - 5:30 pm Job Forum Presidential Address Online Procedures to Claim CME Exhibit Hall – Booth 1520 Ballroom C 3:30 pm - 7:00 pm 9:00 am - 9:25 am Attendees at ACG’s educational activities in San Poster Sessions Exhibit Hall Antonio may claim CME or print a Certificate of Exhibit Hall CD Attendance in one of two ways: Exhibit Hall CD 3:30 pm - 7:00 pm 10:00 am - 4:30 pm ! 1. Visit one of the CME kiosks located in the Henry B. Trainees’ Forum NEW Hands-on Workshop Gonzalez Convention Center to complete your evaluation. Room 206 Center 5:15 pm - 7:00 pm Exhibit Hall – Booth 1313 Print your CME or attendance certificate, or email yourself 10:00 am - 4:30 pm a copy of the certificate to print later. Exhibitor Theater OR Exhibit Hall – Booth 138 Job Forum 5:30 pm - 6:00 pm Exhibit Hall – Booth 1520 2. From your own computer, visit the ACG website at 10:00 am - 4:30 pm www.acg.gi.org to complete your evaluation and print Exhibitor Theater your certificate. Exhibit Hall – Booth 138 6:15 pm - 6:45 pm 2 Schedule at a Glance SCHEDULE Poster Sessions NEW ! Hands-on Workshop ACG 2010 Exhibit Hall CD Center ACG 2010 10:30 am - 4:00 pm Exhibit Hall – Booth 1313 10:00 am - 4:30 pm Thanks to Our Sponsors Exhibitor Theater Exhibit Hall – Booth 138 Job Forum ACG thanks the following sponsors of ACG 2010 12:45 pm - 1:15 pm Exhibit Hall – Booth 1520 exhibit hall events, meeting amenities and 10:00 am - 4:30 pm Lunch Break services, and meeting promotional material. Exhibit Hall CD Poster Sessions 12:45 pm - 2:15 pm Exhibit Hall CD Abbott 10:30 am - 4:00 pm Exhibitor Theater AstraZeneca Exhibit Hall – Booth 138 Lunch Break Axcan Pharma 1:30 pm - 2:00 pm Exhibit Hall CD 12:45 pm - 2:15 pm Braintree Laboratories, Inc. The American Journal of Centocor Ortho Biotech Gastroenterology Lecture Emily Couric Memorial Ballroom C 1&2 Lecture Eurand 3:05 pm - 3:35 pm Ballroom C 1&2 4:30 pm - 5:00 pm Ganaden Biotech, Inc. ACG Business Meeting GI Pathology, PLLC Ballroom C 1&2 5:45 pm - 6:15 pm Wednesday, October 20 PLUS Diagnostics Salix Pharmaceuticals, Inc. President’s Reception Exhibit Hall CD Registration Shire U.S., Inc. 6:15 pm - 7:45 pm East Registration 6:00 am - 12:15 pm Takeda Pharmaceuticals North America, Inc. UCB, Inc. Tuesday, October 19 Optional Breakfast Sessions Vertex Pharmaceuticals (Ticket required. See ticket Registration for room assignment.) East Registration 6:45 am - 8:30 am 6:00 am - 6:15 pm ACG Hands-on Workshop Center supporters: ACG Store Optional Breakfast 8:00 am - 12:15 pm Sessions Apollo Endosurgery (Ticket required. See ticket Annual Meeting Avantis Medical Systems for room assignment.) Ballroom C 6:45 am - 8:30 am 8:30 am - 12:15 pm BARRX Medical Auxiliary Registration/ David Y. Graham Lecture Boston Scientific Hospitality Suite Ballroom C 1&2 CONMED Endoscopic Technologies Grand Hyatt San Antonio, 10:15 am - 10:45 am Republic B Room Cook Medical 8:00 am - 12:00 noon CRH Medical Products Corp. ACG Store CSA Medical 8:00 am - 6:15 pm EndoChoice Annual Meeting ERBE USA, inc. Ballroom C 8:30 am - 6:15 pm Ethicon Endo-Surgery J. Edward Berk Fujinon Inc. Distinguished Lecture Given Imaging, Inc. Ballroom C 1&2 10:00 am - 10:30 am Olympus America, Inc. PENTAX Exhibit Hall Exhibit Hall CD Redfield Corporation 10:00 am - 4:30 pm Sandhill Scientific US Endoscopy 3 Event Locations — Friday, October 15 page 6:30 am–8:00 am Continental Breakfast Outside Rooms 7:00 am–12:35 pm GI Pathology and Imaging Course* Room 217 AB 34 7:15 am–5:15 pm ASGE-sponsored Endoscopy Course* Room 217 CD 30 8:00 am–5:00 pm Practice Management Course* Room 214 AB 27 1:45 pm–5:00 pm What’s New in GI Pharmacology Course* Room 217 AB 36 4:00 pm–8:00 pm Networking, Negotiation and Leadership Skills Workshop Room 209/211 17 Advanced registration required.
Load more

Recommended publications
  • Births, Marriages, and Deaths
    DEC. 31, 1955 MEDICAL NEWS MEDICALBRrsIJOURNAL. 1631 Lead Glazes.-For some years now the pottery industry British Journal of Ophthalmology.-The new issue (Vol. 19, has been forbidden to use any but leadless or "low- No. 12) is now available. The contents include: solubility" glazes, because of the risk of lead poisoning. EXPERIENCE IN CLINIcAL EXAMINATION OP CORNEAL SENsITiVrry. CORNEAL SENSITIVITY AND THE NASO-LACRIMAL REFLEX AFTER RETROBULBAR However, in some teaching establishments raw lead glazes or ANAES rHESIA. Jorn Boberg-Ans. glazes containing a high percentage of soluble lead are still UVEITIS. A CLINICAL AND STATISTICAL SURVEY. George Bennett. INVESTIGATION OF THE CARBONIC ANHYDRASE CONTENT OF THE CORNEA OF used. The Ministry of Education has now issued a memo- THE RABBIT. J. Gloster. randum to local education authorities and school governors HYALURONIDASE IN OCULAR TISSUES. I. SENSITIVE BIOLOGICAL ASSAY FOR SMALL CONCENTRATIONS OF HYALURONIDASE. CT. Mayer. (No. 517, dated November 9, 1955) with the object of INCLUSION BODIES IN TRACHOMA. A. J. Dark. restricting the use of raw lead glazes in such schools. The TETRACYCLINE IN TRACHOMA. L. P. Agarwal and S. R. K. Malik. APPL IANCES: SIMPLE PUPILLOMETER. A. Arnaud Reid. memorandum also includes a list of precautions to be ob- LARGE CONCAVE MIRROR FOR INDIRECT OPHTHALMOSCOPY. H. Neame. served when handling potentially dangerous glazes. Issued monthly; annual subscription £4 4s.; single copy Awards for Research on Ageing.-Candidates wishing to 8s. 6d.; obtainable from the Publishing Manager, B.M.A. House, enter for the 1955-6 Ciba Foundation Awards for research Tavistock Square, London, W.C.1.
    [Show full text]
  • The Management of Acute Hepatic Failure SHEILA SHERLOCK SP PARBHOO
    Postgraduate Medical Journal (July 1971) 47, 493-498. Postgrad Med J: first published as 10.1136/pgmj.47.549.493 on 1 July 1971. Downloaded from The management of acute hepatic failure SHEILA SHERLOCK S. P. PARBHOO Departments of Medicine and Surgery, Royal Free Hospital, London W.C.1 Summary TABLE 1. Royal Free Hospital fulminant hepatitis Acute fulminant hepatitis leads to complex bio- 1959-70 chemical and circulatory disturbances including coma. Number 83 These can be predicted to some extent by knowledge Viral hepatitis 63 of the functions of the normal liver cells. Ineffective Drugs 19 Halothane 6 haemostasis, coma, hypoglycaemia, electrolyte abnor- Amine oxidase inhibitor 9 malities, hypotension and renal circulatory failure are Anti-TB 3 particularly important. Paracetamol 1 Management should be governed by the abnor- Fatty liver pregnancy malities found in the individual patient. Fluid overload Survived 9 (12%Y) and sedation must be avoided. More complex methods Died 74 of temporary hepatic support such as exchange trans- fusion or perfusion of the isolated pig's liver should sonality. The patient may show episodes of anti- Protected by copyright. only be considered after simpler methods of correction social behaviour or character disturbance. Night- have been attempted for a reasonable period of time mares, headache and dizziness are other inaugural and found wanting. non-specific symptoms. Violent behaviour is common The prognosis of acute hepatocellular failure in children, who may also have fits. The acute reaching the stage of deep coma is very poor, the organic reaction with delirium and clouding of mortality being about 80-90 %.
    [Show full text]
  • Combination Therapy for Peptic Ulcer Treatment
    Office europeen des brevets © Publication number: 0 480 691 A2 © EUROPEAN PATENT APPLICATION © Application number : 91309249.0 © int. ci.5: A61K 33/24, A61K 31/60, A61K 31/44, A61K 31/425, © Date of filing : 09.10.91 //(A61K33/24, 31:44, 31:425), (A61K31/60, 31:44, 31:425), (A61K31/44, 31:195), (A61K31/425, 31:195) © Priority: 11.10.90 US 595908 © Inventor: Berlin, Roger G. 519 Mulberry Lane Haverford, PA 19041 (US) (43) Date of publication of application : 15.04.92 Bulletin 92/16 @ Representative : Thompson, John Dr. et al Merck & Co., Inc. European Patent @) Designated Contracting States : Department Terlings Park Eastwick Road CH DE FR GB IT LI NL Harlow, Essex CM20 2QR (GB) © Applicant : MERCK & CO. INC. 126, East Lincoln Avenue P.O. Box 2000 Rahway New Jersey 07065-0900 (US) © Combination therapy for peptic ulcer treatment. © Peptic ulcer disease is treated with a combination therapy of famotidine or omeprazole plus a bismuth salt. CM < CO o 00 LU Jouve, 18, rue Saint-Denis, 75001 PARIS EP 0 480 691 A2 BACKGROUND OF THE INVENTION In the past, treatment of peptic ulcer disease was based on either neutralization of intragastric acidity with antacids or the inhibition of production of acid secretion by H2-receptor antagonists or by proton pump inhibition 5 among others. Using bismuth salts alone to heal ulcers has been shown to be effective presumably because of its effect on Helicobacter pylori. Relapse of Helicobacter positivity, however, has been a problem as has relapse of ulcer disease in patients treated with antisecretory therapy.
    [Show full text]
  • (Public Section) Padma Awards Directory (1954-2009) Year-Wise List Sl
    MINISTRY OF HOME AFFAIRS (Public Section) Padma Awards Directory (1954-2009) Year-Wise List Sl. Prefix First Name Last Name Award State Field Remarks 1954 1 Dr. Sarvapalli Radhakrishnan BR TN Public Affairs Expired 2 Shri Chakravarti Rajagopalachari BR TN Public Affairs Expired 3 Dr. Chandrasekhara Raman BR TN Science & Eng. Expired Venkata 4 Shri Nand Lal Bose PV WB Art Expired 5 Dr. Satyendra Nath Bose PV WB Litt. & Edu. 6 Dr. Zakir Hussain PV AP Public Affairs Expired 7 Shri B.G. Kher PV MAH Public Affairs Expired 8 Shri V.K. Krishna Menon PV KER Public Affairs Expired 9 Shri Jigme Dorji Wangchuk PV BHU Public Affairs 10 Dr. Homi Jehangir Bhabha PB MAH Science & Eng. Expired 11 Dr. Shanti Swarup Bhatnagar PB UP Science & Eng. Expired 12 Shri Mahadeva Iyer Ganapati PB OR Civil Service 13 Dr. J.C. Ghosh PB WB Science & Eng. Expired 14 Shri Maithilisharan Gupta PB UP Litt. & Edu. Expired 15 Shri Radha Krishan Gupta PB DEL Civil Service Expired 16 Shri R.R. Handa PB PUN Civil Service Expired 17 Shri Amar Nath Jha PB UP Litt. & Edu. Expired 18 Shri Malihabadi Josh PB DEL Litt. & Edu. 19 Dr. Ajudhia Nath Khosla PB DEL Science & Eng. Expired 20 Shri K.S. Krishnan PB TN Science & Eng. Expired 21 Shri Moulana Hussain Madni PB PUN Litt. & Edu. Ahmed 22 Shri V.L. Mehta PB GUJ Public Affairs Expired 23 Shri Vallathol Narayana Menon PB KER Litt. & Edu. Expired Wednesday, July 22, 2009 Page 1 of 133 Sl. Prefix First Name Last Name Award State Field Remarks 24 Dr.
    [Show full text]
  • 10. Committee Section (H&Fw)
    10. COMMITTEE SECTION (H&FW) 10.1 Functions of the Committee - The Committee Section (H&FW) is entrusted with the task of providing secretarial assistance to the Department-related Parliamentary Standing Committee on Health & Family Welfare. Like other Department-related Parliamentary Standing Committees serviced by Rajya Sabha Secretariat, the Committee on Health & Family Welfare is governed by Rules 268 to 277 of the Rules of Procedure and Conduct of Business in the Council of States. Further, Rules 74 to 92 of the said Rules relating to Select Committees on Bills also apply mutatis mutandis to the Committee. The Committee on Health & Family Welfare deals with Ministry of Health & Family Welfare which consists of four Departments namely: - (i) Department of Health & Family Welfare; (ii) Department of AYUSH; (iii) Department of Health Research; and (iv) Department of AIDS Control The functions assigned to the Committee, as enumerated in Rule 270 of the Rules of Procedure and Conduct of Business in the Council of States are (i) consideration of Demands-for- Grants of the Ministry of Health and Family Welfare, (ii) examination of Bills pertaining to the Ministry when referred to the Committee by the Hon’ble Chairman or Speaker, as the case may be, (iii) consideration of Annual Reports of the Ministry, and (iv) consideration of national basic long- term policy documents presented to both the Houses and referred to the Committee by the Hon’ble Chairman or the Speaker, as the case may be, and report thereon. 10.2 Tenure of the Committee: The Committee was reconstituted on the 31st August, 2010 under the chairmanship of Shri Brajesh Pathak, M.P.
    [Show full text]
  • The Toronto Consensus for the Treatment of Helicobacter Pylori Infection in Adults Carlo A
    Gastroenterology 2016;151:51–69 CONSENSUS STATEMENT The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults Carlo A. Fallone,1 Naoki Chiba,2,3 Sander Veldhuyzen van Zanten,4 Lori Fischbach,5 Javier P. Gisbert,6 Richard H. Hunt,3,7 Nicola L. Jones,8 Craig Render,9 Grigorios I. Leontiadis,3,7 Paul Moayyedi,3,7 and John K. Marshall3,7 1Division of Gastroenterology, McGill University Health Centre, McGill University, Montreal, Quebec, Canada; 2Guelph GI and Surgery Clinic, Guelph, Ontario, Canada; 3Division of Gastroenterology, McMaster University, Hamilton, Ontario, Canada; 4Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; 5Department of Epidemiology, University of Arkansas for Medical Sciences, Little Rock, Arkansas; 6Gastroenterology Service, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain; 7Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada; 8Division of Gastroenterology, Hepatology, and Nutrition, The Hospital for Sick Children, Departments of Paediatrics and Physiology, University of Toronto, Toronto, Ontario, Canada; and 9Kelowna General Hospital, Kelowna, British Columbia, Canada This article has an accompanying continuing medical education activity, also eligible for MOC credit, on page e25. Learning Objective: Upon completion of this examination, successful learners will be able to establish a treatment plan for patients with H pylori infection. BACKGROUND & AIMS: Helicobacter pylori infection is lthough the prevalence of H pylori is decreasing in increasingly difficult to treat. The purpose of these consensus A some parts of the world, the infection remains pre- statements is to provide a review of the literature and specific, sent in 28% to 84% of subjects depending on the population updated recommendations for eradication therapy in adults.
    [Show full text]
  • Levofloxacin, Metronidazole, and Lansoprazole Triple Therapy Compared to Quadruple Therapy As a Second-Line Treatment of Helicobacter Pylori Infection in Korea
    Gut and Liver, Vol. 7, No. 4, July 2013, pp. 406-410 ORiginal Article Levofloxacin, Metronidazole, and Lansoprazole Triple Therapy Compared to Quadruple Therapy as a Second-Line Treatment of Helicobacter pylori Infection in Korea Ji Yoon Moon*, Gwang Ha Kim*, Hyun Seok You†, Bong Eun Lee*, Dong Yeop Ryu*, Jae Hoon Cheong*, Jung Im Jung*, Jae Hoon Jeong‡, Chul Soo Song‡, and Geun Am Song* *Department of Internal Medicine, Pusan National University School of Medicine, †Department of Internal Medicine, Busan Medical Center, and ‡Department of Internal Medicine, Good Samsun Hospital, Busan, Korea Background/Aims: Several rescue therapies have been rec- INTRODUCTION ommended to eradicate Helicobacter pylori infection in pa- tients with a failure of first-line eradication therapy, but they Helicobacter pylori infection is recognized as an important still fail in more than 20% of cases. The aim of this study was contributor to nonulcer dyspepsia, peptic ulcer disease, gastric to evaluate the efficacy and safety of levofloxacin, metroni- mucosa-associated lymphoid tissue lymphoma, and gastric dazole, and lansoprazole (LML) triple therapy relative to qua- cancer. Eradication of H. pylori significantly reduces the re- druple therapy as a second-line treatment. Methods: In total, lapse rate of peptic ulcer disease.1,2 A triple therapy, comprising 113 patients who failed first-line triple therapy for H. pylori amoxicillin, clarithromycin, and a proton pump inhibitor (PPI), infection were randomly assigned to two groups: LML for 7 is the first-line treatment suggested by international guide- days and tetracycline, bismuth subcitrate, metronidazole and lines.3-5 However, several large clinical trials have shown that lansoprazole (quadruple) for 7 days.
    [Show full text]
  • S.No. Sector Core Group Constituted?
    APPENDIX I List of Sectors S.No. Sector Core Group Constituted? 1 Automobile Yes 2 Beauty and Wellness Yes 3 Construction, Construction Material, and Real Estate Yes 4 Electronics & Hardware Yes 5 Fabrication Yes 6 Food Processing & Preservation Yes 7 IT & ITES Yes 8 Power Generation, Transmission, Distribution, Wiring, and Yes Electrical Equipments 9 Production & Manufacturing Yes 10 Textiles and Apparel Yes 11 Travel, Tourism, and Hospitality Yes 12 Organized Retail No 13 Telecommunications No 14 Industrial Automation & Instrumentation No 15 Handicrafts No 16 Mining & Mineral Processing No 17 Plastics No 18 Leather & Leather Goods No 19 Gems And Jewellery No 20 Agriculture, Horticulture, Floriculture No 21 Dairy, Meat, Poultry, Fisheries No 22 Rubber No 23 Health Care No 24 Entertainment, Media, Advertising, Event Management No 25 Banking Financial Service & Insurance (BFSI) No ANNEXURE I List of Sectors S.No. Sector 1 Automobile 2 Beauty and Wellness 3 Construction, Construction Material, and Real Estate 4 Electronics & Hardware 5 Fabrication 6 Food Processing & Preservation 7 IT & ITES 8 Power Generation, Transmission, Distribution, Wiring, and Electrical Equipments 9 Production & Manufacturing 10 Textiles and Apparel 11 Travel, Tourism, and Hospitality ANNEXURE II CORE GROUP FOR AUTOMOBILE SECTOR S.No. Name and Designation Contribution in Core Group 1 Shri T.C. Saravanabava, DDG(AT), DGET Mentor Headquarters 2 Mr. K.S. Rao, JDT, CSTARI, Kolkata Representative of CSTARI 3 Mr. Ravichandran, DDT, NIMI Chennai Representative of NIMI 4 Mr. R.K. Gowda, DDT, ATI Hyderabad Champion Master Trainer 5 Mr. Yuvraj, DDT, ATI Chennai Member 6 Mr. G. Venktesh, ADT, ATI Hyderabad Member 7 Mr.
    [Show full text]
  • King's Research Portal
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by King's Research Portal King’s Research Portal DOI: 10.1016/j.healthplace.2016.08.004 Document Version Peer reviewed version Link to publication record in King's Research Portal Citation for published version (APA): Murray, S. F., Bisht, R., & Pitchforth, E. (2016). Emplacing India's “medicities”. HEALTH AND PLACE, 42, 69-78. https://doi.org/10.1016/j.healthplace.2016.08.004 Citing this paper Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination, volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are again advised to check the publisher's website for any subsequent corrections. General rights Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights. •Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research. •You may not further distribute the material or use it for any profit-making activity or commercial gain •You may freely distribute the URL identifying the publication in the Research Portal Take down policy If you believe that this document breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim.
    [Show full text]
  • Emplacing India's Medicities MURRAY Firstonline28september2016 GREEN
    King’s Research Portal DOI: 10.1016/j.healthplace.2016.08.004 Document Version Peer reviewed version Link to publication record in King's Research Portal Citation for published version (APA): Murray, S. F., Bisht, R., & Pitchforth, E. (2016). Emplacing India's “medicities”. HEALTH AND PLACE, 42, 69-78. https://doi.org/10.1016/j.healthplace.2016.08.004 Citing this paper Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination, volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are again advised to check the publisher's website for any subsequent corrections. General rights Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights. •Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research. •You may not further distribute the material or use it for any profit-making activity or commercial gain •You may freely distribute the URL identifying the publication in the Research Portal Take down policy If you believe that this document breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim.
    [Show full text]
  • Report on Mapping of Healthcare Sector in India
    Report on Mapping of Healthcare Sector in India SWECARE AND SWEDISH TRADE COUNCIL, INDIA 2012 This page has been intentionally left blank Page 2 of 294 Table of Contents 1. EXECUTIVE SUMMARY ......................................................................................................................... 8 1.1. OVERVIEW - HEALTH SITUATION IN INDIA .................................................................................................... 8 1.2. SHORTLISTED SECTORS AND MAJOR BUSINESS OPPORTUNITIES............................................................... 11 1.3. PERCEPTION REGARDING SWEDISH TECHNOLOGIES AND SOLUTIONS ........................................................ 22 2. HEALTHCARE SECTOR IN INDIA ....................................................................................................... 24 2.1. OVERVIEW ............................................................................................................................................. 24 3. MAJOR HEALTHCARE PROGRAMS .................................................................................................. 33 3.1. NATIONAL RURAL HEALTH MISSION ......................................................................................................... 34 3.2. NATIONAL URBAN HEALTH MISSION ......................................................................................................... 39 3.3. NATIONAL VECTOR BORNE DISEASE CONTROL PROGRAM ........................................................................ 42 3.4. REVISED
    [Show full text]
  • Dr. Devi Shetty - Doctor of Science
    Dr. Devi Shetty - Doctor of Science Dr. Devi Shetty, Chairman, Narayana Health Group was awarded today with an honorary doctorate degree of Doctor of Science for his contributions and commitment to the field of Medical Science. The Doctorate was conferred upon him with the consent of the President of India Pranab Mukherjee to the proposal made by Indian Institute of Technology Madras (IIT-M). The Honorary Degree was bestowed by Prof. Bhaskar Rammurthi – Director, IIT- M as part of 51st convocation at a ceremony in Chennai. Receiving the award, Dr. Devi Shetty, Chairman, Narayana Health, said, A tribute to a person is always an acknowledgment of his ideologies, efforts and the purpose to which that person has devoted his life. It has been our constant endeavor at Narayana Health to bring down the cost of healthcare and make quality healthcare accessible to all sections of society. Thus, I share this award with all those who have also dedicated themselves for this cause. He also added, Consolidation is the only way to reach out to a larger level, for which it s important to partner with multiple stakeholders, including academia. Dr. Devi Shetty is also the recipient of the prestigious civilian award, Padma Bhushan for his contributions in the field of healthcare, especially heart care After completing his graduate degree in Medicine and post-graduate work in General Surgery from Kasturba Medical College, Mangalore, he trained in cardiac surgery at Guys Hospital in the United Kingdom. He performed the first neonatal heart surgery in the country on a 9-day-old baby.
    [Show full text]